Shiseido has announced the launch of its first medical aesthetics brand, RQ Pyology, in the Chinese market. The premium brand will focus on skincare and medical aesthetic technologies, targeting consumers seeking clinical-level results and high-end treatment experiences. RQ Pyology will offer post-procedure skin recovery solutions through collaborations with Chinese medical institutions, with products such as the RQ Pyology Brightening Essence and Sunscreen Emulsion already having completed regulatory filings in China. Distribution will be through medical clinic channels.